MENU
NVCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NovoCure (NVCR) Ownership - Who owns NovoCure?
NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
1.66B
P/E Ratio
N/A
Total Cash
910.62M
Projected Growth
N/A
Total Debt
596.24M
Revenue
509.34M
Risk (Beta)
0.53
Dividend Yield
N/A
Total Cash/Share
8.50
Total Debt/Equity
N/A
Revenue/Share
4.79 USD as % of share price
Fundamentals
NVCR
Capitalization
1.66B
P/E Ratio
N/A
Risk (Beta)
0.53
Dividend Yield
N/A
Total Cash
911M
Total Cash/Share
8.50
Total Debt
596M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.79%
Revenue
509M
ROE
N/A
Book Value
362M
P/B Ratio
4.58
Cash Flow
N/A
Earnings
-1.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
5.78
Current Revenue Per Employee
92074.33
Dividends Per Share - Security
N/A
EBITDA
-177.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.67
Revenue To Assets
-17.71
Shares Held By Institutions
2.52B
Shares Outstanding - Current
107M
Total Liabilities
784M
Total Volume MTD
N/A
Value
-1
Gain YTD
-47.718
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a commercial-stage oncology company
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com